These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6999345)

  • 1. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project.
    Coronary Drug Project Research Group
    N Engl J Med; 1980 Oct; 303(18):1038-41. PubMed ID: 6999345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Report of the Committee of Principal Investigators.
    Lancet; 1984 Sep; 2(8403):600-4. PubMed ID: 6147641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of clofibrate on progression of coronary disease: a prospective angiographic study in man.
    Cohn K; Sakai FJ; Langston MF
    Am Heart J; 1975 May; 89(5):591-8. PubMed ID: 1091127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallbladder disease as a side effect of drugs influencing lipid metabolism. Experience in the Coronary Drug Project.
    Coronary Drug Project Research Group
    N Engl J Med; 1977 May; 296(21):1185-90. PubMed ID: 323705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators.
    Lancet; 1980 Aug; 2(8191):379-85. PubMed ID: 6105515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of treatment adherence in the coronary drug project.
    N Engl J Med; 1981 Mar; 304(10):612-3. PubMed ID: 7005674
    [No Abstract]   [Full Text] [Related]  

  • 7. Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians.
    Research Committee of the Scottish Society of Physicians
    Br Med J; 1971 Dec; 4(5790):775-84. PubMed ID: 4943606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofibrate and niacin in coronary heart disease.
    JAMA; 1975 Jan; 231(4):360-81. PubMed ID: 1088963
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholesterol, coronaries, clofibrate and death.
    Oliver MF
    N Engl J Med; 1978 Dec; 299(24):1360-2. PubMed ID: 362204
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid.
    Carlson LA; Rosenhamer G
    Acta Med Scand; 1988; 223(5):405-18. PubMed ID: 3287837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin.
    Stamler J
    Adv Exp Med Biol; 1977; 82():52-75. PubMed ID: 335823
    [No Abstract]   [Full Text] [Related]  

  • 12. Clofibrate: a final verdict?
    Lancet; 1978 Nov; 2(8100):1131-2. PubMed ID: 82687
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholesterol, clofibrate and ischaemic heart disease. Facts and emotions around.
    Fejfar Z
    Cor Vasa; 1979; 21(6):377-9. PubMed ID: 397875
    [No Abstract]   [Full Text] [Related]  

  • 14. The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group.
    JAMA; 1972 May; 220(7):996-1008. PubMed ID: 4337170
    [No Abstract]   [Full Text] [Related]  

  • 15. Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region.
    Br Med J; 1971 Dec; 4(5790):767-75. PubMed ID: 4943605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence adjustment in the Coronary Drug Project: A call for better per-protocol effect estimates in randomized trials.
    Murray EJ; Hernán MA
    Clin Trials; 2016 Aug; 13(4):372-8. PubMed ID: 26951361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative clofibrate trial.
    Vaisrub S
    JAMA; 1979 Jun; 241(24):2638. PubMed ID: 374769
    [No Abstract]   [Full Text] [Related]  

  • 18. Ischemic heart disease: a secondary prevention trial using clofibrate (Atromid-S).
    Oliver MF
    Adv Exp Med Biol; 1972; 26(0):255-9. PubMed ID: 4679687
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholesterol, coronaries, clofibrate and death.
    N Engl J Med; 1979 Mar; 300(9):497-8. PubMed ID: 759942
    [No Abstract]   [Full Text] [Related]  

  • 20. Clofibrate in coronary heart disease. Effect on morbidity and mortality.
    Krasno LR; Kidera GJ
    JAMA; 1972 Feb; 219(7):845-51. PubMed ID: 5066667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.